Modified Taurine Polyphenol Conjugate for Metabolic Syndrome
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for metabolic diseases such as obesity, diabetes, and thrombotic disorders are inadequate, as existing therapies either do not effectively address insulin resistance or cause significant side effects, and there is a need for a substance that can simultaneously manage blood glucose levels, blood pressure, and cholesterol levels.
Innovation Solution
A modified taurine with distinct physical properties is developed, which is used as an active ingredient in a pharmaceutical composition that can be administered orally or intravenously, combining with sugars, polyphenols, and amino acids to enhance therapeutic effects, including reducing triglyceride levels and exhibiting anti-thrombotic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional taurine is used for treating metabolic diseases, then it can be administered as a simple amino acid supplement, but it lacks therapeutic activity and cannot effectively manage blood glucose, blood pressure, or cholesterol levels
Solution Approach 1:
The patent applies parameter changes by modifying the molecular structure of taurine through conjugation with polyphenols (changing chemical composition parameters) and controlling crystallization conditions (changing physical parameters like temperature and solvent composition). These parameter changes transform ordinary taurine into modified taurine crystals with enhanced therapeutic activity for managing metabolic diseases including blood glucose, blood pressure, and cholesterol levels.
Solution Approach 2:
The patent creates composite materials by forming conjugates between taurine and polyphenolic compounds. The modified taurine represents a composite structure where taurine molecules are chemically bonded to polyphenol units, combining the properties of both components to achieve enhanced therapeutic effects that neither component possesses alone.
2Adaptability or versatility
If existing treatments are used for metabolic diseases, then they can address individual symptoms, but they cause significant side effects and do not effectively manage multiple parameters simultaneously
Solution Approach 1:
The modified taurine exhibits multi-functionality by simultaneously addressing multiple metabolic parameters including blood glucose levels, blood pressure, cholesterol levels, and triglyceride levels. A single compound acts on multiple targets in the metabolic system, providing comprehensive management of metabolic syndrome without the need for multiple separate medications that would increase side effect risk.
Solution Approach 2:
The modified taurine acts as an intermediary substance that mediates between various metabolic pathways. The polyphenol-conjugated taurine structure serves as a bridge that can interact with multiple metabolic targets, facilitating coordinated regulation of glucose metabolism, lipid metabolism, and blood pressure control through a single therapeutic agent.
Data Source
AI summary
The present invention relates to a modified taurine, and a pharmaceutical composition for preventing or treating metabolic disease or a food composition, which contains the modified taurine as an active ingredient. More specifically, the modified taurine of the present invention has physical properties different from those of existing taurine, and has significant effects on the prevention and treatment of metabolic syndrome, including antithrombotic effects.